Strategic Financial Concepts LLC bought a new stake in shares of Bain Capital Specialty Finance, Inc. (NYSE:BCSF - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 64,771 shares of the company's stock, valued at approximately $1,135,000. Strategic Financial Concepts LLC owned 0.10% of Bain Capital Specialty Finance as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors have also added to or reduced their stakes in BCSF. Van ECK Associates Corp boosted its stake in Bain Capital Specialty Finance by 13.8% in the 4th quarter. Van ECK Associates Corp now owns 1,088,471 shares of the company's stock worth $19,070,000 after purchasing an additional 131,860 shares in the last quarter. International Assets Investment Management LLC boosted its stake in Bain Capital Specialty Finance by 1,551.4% in the 3rd quarter. International Assets Investment Management LLC now owns 526,706 shares of the company's stock worth $87,430,000 after purchasing an additional 494,812 shares in the last quarter. Hennion & Walsh Asset Management Inc. boosted its stake in Bain Capital Specialty Finance by 0.5% in the 4th quarter. Hennion & Walsh Asset Management Inc. now owns 468,313 shares of the company's stock worth $8,205,000 after purchasing an additional 2,445 shares in the last quarter. Columbus Macro LLC purchased a new position in Bain Capital Specialty Finance during the 4th quarter worth approximately $5,544,000. Finally, Allworth Financial LP purchased a new position in Bain Capital Specialty Finance during the 4th quarter worth approximately $5,459,000.
Bain Capital Specialty Finance Price Performance
BCSF traded up $0.08 on Thursday, hitting $18.62. 174,930 shares of the company's stock were exchanged, compared to its average volume of 200,762. Bain Capital Specialty Finance, Inc. has a fifty-two week low of $15.21 and a fifty-two week high of $18.65. The company has a current ratio of 1.41, a quick ratio of 1.41 and a debt-to-equity ratio of 1.13. The firm has a 50-day moving average price of $17.68 and a 200-day moving average price of $17.05. The stock has a market cap of $1.20 billion, a price-to-earnings ratio of 9.35 and a beta of 1.10.
Analysts Set New Price Targets
Separately, Wells Fargo & Company lifted their target price on shares of Bain Capital Specialty Finance from $17.00 to $18.00 and gave the company an "overweight" rating in a report on Wednesday, January 29th.
View Our Latest Report on Bain Capital Specialty Finance
Bain Capital Specialty Finance Company Profile
(
Free Report)
Bain Capital Specialty Finance, Inc is business development company specializing in direct loans to middle-market companies. The fund seeks to invest in senior investments with a first or second lien on collateral, senior first lien, stretch senior, senior second lien, unitranche, mezzanine debt, junior securities, other junior investments, and secondary purchases of assets or portfolios that primarily consist of middle-market corporate debt.
Featured Articles

Before you consider Bain Capital Specialty Finance, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bain Capital Specialty Finance wasn't on the list.
While Bain Capital Specialty Finance currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.